Global Pulmonary Edema Market Size, Status, Research and Forecast 2019-2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 350447

Pulmonary edema or lung congestion is a medical condition characterized by the presence of excessive fluid in the lungs. This may interfere with the exchange of gases leading to respiratory failures.
America dominates the global pulmonary edema market owing to a well-developed healthcare sector and high per capita healthcare expenditure. Moreover, the presence of developed economies like U.S. and Canada and global players such as Pfizer Inc., Edwards Lifesciences Corporation, ARGON MEDICAL, and others within the regional boundaries of the Americas fuels the market growth.
In 2018, the global Pulmonary Edema market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Pulmonary Edema status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pulmonary Edema development in United States, Europe and China.

The key players covered in this study
Pfizer Inc. (U.S.)
ARGON MEDICAL (U.S.)
Edwards Lifesciences Corporation (U.S.)
BD (U.S.)
Alcaliber S.A. (Spain)
Lupin Pharmaceuticals, Inc. (India)
Vitaltec Corporation (China)
Medtronic (U.S.)
Koninklijke Philips N.V. (The Netherlands)
Siemens Healthcare GmbH (Germany)
Hitachi Medical Corporation (U.S.)
Canon Medical Systems Corporation (Japan)

Market segment by Type, the product can be split into
Diagnosis
Treatment

Market segment by Application, split into
Hospitals & Clinics
Academic Institutes
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pulmonary Edema status, future forecast, growth opportunity, key market and key players.
To present the Pulmonary Edema development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pulmonary Edema are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pulmonary Edema Market Size Growth Rate by Type (2014-2025)
1.4.2 Diagnosis
1.4.3 Treatment
1.5 Market by Application
1.5.1 Global Pulmonary Edema Market Share by Application (2014-2025)
1.5.2 Hospitals & Clinics
1.5.3 Academic Institutes
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pulmonary Edema Market Size
2.2 Pulmonary Edema Growth Trends by Regions
2.2.1 Pulmonary Edema Market Size by Regions (2014-2025)
2.2.2 Pulmonary Edema Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Pulmonary Edema Market Size by Manufacturers
3.1.1 Global Pulmonary Edema Revenue by Manufacturers (2014-2019)
3.1.2 Global Pulmonary Edema Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pulmonary Edema Market Concentration Ratio (CR5 and HHI)
3.2 Pulmonary Edema Key Players Head office and Area Served
3.3 Key Players Pulmonary Edema Product/Solution/Service
3.4 Date of Enter into Pulmonary Edema Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pulmonary Edema Market Size by Type (2014-2019)
4.2 Global Pulmonary Edema Market Size by Application (2014-2019)

5 United States
5.1 United States Pulmonary Edema Market Size (2014-2019)
5.2 Pulmonary Edema Key Players in United States
5.3 United States Pulmonary Edema Market Size by Type
5.4 United States Pulmonary Edema Market Size by Application

6 Europe
6.1 Europe Pulmonary Edema Market Size (2014-2019)
6.2 Pulmonary Edema Key Players in Europe
6.3 Europe Pulmonary Edema Market Size by Type
6.4 Europe Pulmonary Edema Market Size by Application

7 China
7.1 China Pulmonary Edema Market Size (2014-2019)
7.2 Pulmonary Edema Key Players in China
7.3 China Pulmonary Edema Market Size by Type
7.4 China Pulmonary Edema Market Size by Application

8 Japan
8.1 Japan Pulmonary Edema Market Size (2014-2019)
8.2 Pulmonary Edema Key Players in Japan
8.3 Japan Pulmonary Edema Market Size by Type
8.4 Japan Pulmonary Edema Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pulmonary Edema Market Size (2014-2019)
9.2 Pulmonary Edema Key Players in Southeast Asia
9.3 Southeast Asia Pulmonary Edema Market Size by Type
9.4 Southeast Asia Pulmonary Edema Market Size by Application

10 India
10.1 India Pulmonary Edema Market Size (2014-2019)
10.2 Pulmonary Edema Key Players in India
10.3 India Pulmonary Edema Market Size by Type
10.4 India Pulmonary Edema Market Size by Application

11 Central & South America
11.1 Central & South America Pulmonary Edema Market Size (2014-2019)
11.2 Pulmonary Edema Key Players in Central & South America
11.3 Central & South America Pulmonary Edema Market Size by Type
11.4 Central & South America Pulmonary Edema Market Size by Application

12 International Players Profiles
12.1 Pfizer Inc. (U.S.)
12.1.1 Pfizer Inc. (U.S.) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pulmonary Edema Introduction
12.1.4 Pfizer Inc. (U.S.) Revenue in Pulmonary Edema Business (2014-2019)
12.1.5 Pfizer Inc. (U.S.) Recent Development
12.2 ARGON MEDICAL (U.S.)
12.2.1 ARGON MEDICAL (U.S.) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pulmonary Edema Introduction
12.2.4 ARGON MEDICAL (U.S.) Revenue in Pulmonary Edema Business (2014-2019)
12.2.5 ARGON MEDICAL (U.S.) Recent Development
12.3 Edwards Lifesciences Corporation (U.S.)
12.3.1 Edwards Lifesciences Corporation (U.S.) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pulmonary Edema Introduction
12.3.4 Edwards Lifesciences Corporation (U.S.) Revenue in Pulmonary Edema Business (2014-2019)
12.3.5 Edwards Lifesciences Corporation (U.S.) Recent Development
12.4 BD (U.S.)
12.4.1 BD (U.S.) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pulmonary Edema Introduction
12.4.4 BD (U.S.) Revenue in Pulmonary Edema Business (2014-2019)
12.4.5 BD (U.S.) Recent Development
12.5 Alcaliber S.A. (Spain)
12.5.1 Alcaliber S.A. (Spain) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pulmonary Edema Introduction
12.5.4 Alcaliber S.A. (Spain) Revenue in Pulmonary Edema Business (2014-2019)
12.5.5 Alcaliber S.A. (Spain) Recent Development
12.6 Lupin Pharmaceuticals, Inc. (India)
12.6.1 Lupin Pharmaceuticals, Inc. (India) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pulmonary Edema Introduction
12.6.4 Lupin Pharmaceuticals, Inc. (India) Revenue in Pulmonary Edema Business (2014-2019)
12.6.5 Lupin Pharmaceuticals, Inc. (India) Recent Development
12.7 Vitaltec Corporation (China)
12.7.1 Vitaltec Corporation (China) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pulmonary Edema Introduction
12.7.4 Vitaltec Corporation (China) Revenue in Pulmonary Edema Business (2014-2019)
12.7.5 Vitaltec Corporation (China) Recent Development
12.8 Medtronic (U.S.)
12.8.1 Medtronic (U.S.) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pulmonary Edema Introduction
12.8.4 Medtronic (U.S.) Revenue in Pulmonary Edema Business (2014-2019)
12.8.5 Medtronic (U.S.) Recent Development
12.9 Koninklijke Philips N.V. (The Netherlands)
12.9.1 Koninklijke Philips N.V. (The Netherlands) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pulmonary Edema Introduction
12.9.4 Koninklijke Philips N.V. (The Netherlands) Revenue in Pulmonary Edema Business (2014-2019)
12.9.5 Koninklijke Philips N.V. (The Netherlands) Recent Development
12.10 Siemens Healthcare GmbH (Germany)
12.10.1 Siemens Healthcare GmbH (Germany) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Pulmonary Edema Introduction
12.10.4 Siemens Healthcare GmbH (Germany) Revenue in Pulmonary Edema Business (2014-2019)
12.10.5 Siemens Healthcare GmbH (Germany) Recent Development
12.11 Hitachi Medical Corporation (U.S.)
12.12 Canon Medical Systems Corporation (Japan)

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details